Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Ana Garcia-Osta"'
Publikováno v:
IBRO Neuroscience Reports, Vol 15, Iss , Pp S297- (2023)
Externí odkaz:
https://doaj.org/article/e670190129a844a5b4d51e8d04e27084
Publikováno v:
IBRO Neuroscience Reports, Vol 15, Iss , Pp S410-S411 (2023)
Externí odkaz:
https://doaj.org/article/3e137ae5db014270a3f88eae1ca3f50c
Autor:
Sara Badesso, Paz Cartas-Cejudo, Maria Espelosin, Enrique Santamaria, Mar Cuadrado-Tejedor, Ana Garcia-Osta
Publikováno v:
Pharmaceutics, Vol 15, Iss 1, p 82 (2022)
Docosahexaenoic acid (DHA), the most abundant polyunsaturated fatty acid in the brain, is essential for successful aging. In fact, epidemiological studies have demonstrated that increased intake of DHA might lower the risk for developing Alzheimer’
Externí odkaz:
https://doaj.org/article/287e03cf012247b4a0d824d2bdea7698
Autor:
Mar Cuadrado-Tejedor, Marta Pérez-González, Cristina García-Muñoz, Damián Muruzabal, Carolina García-Barroso, Obdulia Rabal, Víctor Segura, Juan A. Sánchez-Arias, Julen Oyarzabal, Ana Garcia-Osta
Publikováno v:
Frontiers in Aging Neuroscience, Vol 11 (2019)
The discouraging results with therapies for Alzheimer’s disease (AD) in clinical trials, highlights the urgent need to adopt new approaches. Like other complex diseases, it is becoming clear that AD therapies should focus on the simultaneous modula
Externí odkaz:
https://doaj.org/article/406af94d56d34149a280e4d9333bb21a
Autor:
Maria Pascual‐Lucas, Silvia Viana da Silva, Marianna Di Scala, Carolina Garcia‐Barroso, Gloria González‐Aseguinolaza, Christophe Mulle, Cristina M Alberini, Mar Cuadrado‐Tejedor, Ana Garcia‐Osta
Publikováno v:
EMBO Molecular Medicine, Vol 6, Iss 10, Pp 1246-1262 (2014)
Abstract Insulin‐like growth factor 2 (IGF2) was recently found to play a critical role in memory consolidation in rats and mice, and hippocampal or systemic administration of recombinant IGF2 enhances memory. Here, using a gene therapy‐based app
Externí odkaz:
https://doaj.org/article/912759b800874d93875faf0e67d55253
Publikováno v:
Mediators of Inflammation, Vol 2015 (2015)
Phosphodiesterase type 5 inhibitors (PDE5-Is) have recently emerged as a potential therapeutic strategy for neuroinflammatory, neurodegenerative, and memory loss diseases. Mechanistically, PDE5-Is produce an anti-inflammatory and neuroprotection effe
Externí odkaz:
https://doaj.org/article/9fb7ee93795b4fa486c5da33aade69c6
Autor:
Sara Badesso, Paz Cartas-Cejudo, Maria Espelosin, Enrique Santamaria, Mar Cuadrado-Tejedor, Ana Garcia-Osta
Publikováno v:
Pharmaceutics; Volume 15; Issue 1; Pages: 82
Docosahexaenoic acid (DHA), the most abundant polyunsaturated fatty acid in the brain, is essential for successful aging. In fact, epidemiological studies have demonstrated that increased intake of DHA might lower the risk for developing Alzheimer’
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19aff86a577ddde3eae94ec254ab24ef
https://hdl.handle.net/2454/45243
https://hdl.handle.net/2454/45243
Autor:
Carolina Aguado, Sara Badesso, José Martínez-Hernández, Alejandro Martín-Belmonte, Rocío Alfaro-Ruiz, Miriam Fernández, Ana Esther Moreno-Martínez, Mar Cuadrado-Tejedor, Ana García-Osta, Rafael Luján
Publikováno v:
Neural Regeneration Research, Vol 19, Iss 9, Pp 2068-2074 (2024)
[INLINE:1] Plaques of amyloid-β (Aβ) and neurofibrillary tangles are the main pathological characteristics of Alzheimer's disease (AD). However, some older adult people with AD pathological hallmarks can retain cognitive function. Unraveling the fa
Externí odkaz:
https://doaj.org/article/cb89811a5f93417db9ab17bae6510143
Autor:
Maria Espelosin, Diego Sucunza, Marta Pérez-González, Mar Cuadrado-Tejedor, Susana Ursua, Rafael Luján, Sara Badesso, Miren Roldan, Maite Mendioroz, Ana Garcia-Osta
Publikováno v:
Progress in neurobiology. 191
Clinical studies revealed that some aged-individuals accumulate a significant number of histopathological Alzheimer´s disease (AD) lesions in their brain, yet without developing any signs of dementia. Animal models of AD represent suitable tools to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd1c106f0b2201a0b4fc2bcdee828f75
https://pubmed.ncbi.nlm.nih.gov/32380223
https://pubmed.ncbi.nlm.nih.gov/32380223
Autor:
Mar Cuadrado-Tejedor, Ana Garcia-Osta
Reprofiling is a strategy in which existing drugs are used to treat conditions for which they were not designed. This is a relatively novel strategy that may accelerate the possibility of discovering new effective therapies to both prevent and treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::503342c3519709b00fbf9f52799c6299
https://doi.org/10.1016/b978-0-12-815868-5.00014-1
https://doi.org/10.1016/b978-0-12-815868-5.00014-1